BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months
TLX upcoming catalysts
Telix Pharmaceuticals (Innovations) Pty Limited: 1 upcoming industry Phase 2/3 trial readout(s) in the next 90 days (1 Phase 3), 0 upcoming FDA decision event(s), and in the last 12 months 2 readout(s) and 2 FDA event(s). Subscribe to TLX (.ics).
Drugs: 68Ga-PSMA-11
Upcoming FDA decision events
| Date | Event | Status | Company | Drug | Source |
|---|---|---|---|---|---|
| No upcoming PDUFA date or AdCom found. | |||||
Upcoming trial readouts
| Readout | Phase | Sponsor | Trial | Conditions | Status | Enrollment |
|---|---|---|---|---|---|---|
| 2027-01 est. | P3 | Telix Pharmaceuticals (Innovations) Pty Limited TLX | NCT07052214 PSMA PET Combined With MRI for the Detection of PCa | PCA; Prostate Cancer; Prostatic Neoplasm; PSMA PET; Diagnostic Imaging; Elevated PSA; Positron Emiss | active not recruiting | 338 |
FDA decision events, last 12 months
| Date | Event | Status | Company | Drug | Source |
|---|---|---|---|---|---|
| 2026-09-11 | FDA approval | approved | TELIX TLX | PIXCLARA | Approved 2026-09-11: PIXCLARA (NDA218592 ORIG1) |
| 2026-04-10 | Complete response letter | complete response | Telix Pharmaceuticals (US) Inc. TLX | 8°Zr-TLX250 | CRL 2026-04-10: Telix Pharmaceuticals (US) Inc. BLA 761401 (8°Zr-TLX250) |
Trial readouts, last 12 months
| Readout | Phase | Sponsor | Trial | Conditions | Status | Enrollment |
|---|---|---|---|---|---|---|
| 2026-06-30 est. | P3 | Telix Pharmaceuticals (Innovations) Pty Limited TLX | NCT06750419 89Zr-TLX250 for PET/CT Imaging of ccRCC - ZIRCON-CP Study | Clear Cell Renal Cell Carcinoma | recruiting | 82 |
| 2025-12-30 est. | P3 | Telix Pharmaceuticals (Innovations) Pty Limited TLX | NCT05847348 68Ga-PSMA-11 Efficacy in Detecting BCR Prostate Cancer in Chinese Patients | Biochemical Recurrence of Malignant Neoplasm of Prostate; Prostate Cancer; BCR Prostate Carcinoma | unknown | 110 |
Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line
results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are
company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA
(openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score.
Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP
readout_calendar / fda_decisions. Not investment advice.